The effects of the fluorinated benzodiazepine compound flunitrazepam were studied in eighty patients. The drug was administered intravenously in a standard dose of 2 mg, 3 mg, or 4 mg to supplement lumbar epidural analgesia. Induction was smooth and pleasant. The sleep onset time was dose related and exceeded one minute in the majority of patients. Sleep was invariably produced in patients receiving 4 mg but at lower dosage some patients failed to become unconscious. Pain in the arm during injection was a common feature. The respiratory rate was slightly increased, but in two patients apnoea occurred at induction. The cardiovascular system was minimally depressed with a small decrease in systolic blood pressure and pulse rate. Recovery from sleep was slow but sequelae were minimal. The sedative and amnesic properties contributed significantly to the high rate of patient acceptance.
INTRODUCTION
Flunitrazepam (Ro5-4200), a new and extremely potent benzodiazepine derivative, differs structurally from diazepam by having fluorine in the phenol ring and the nitro group substituted for the chloride radical ( Figure 1 ). Favourable reports on its use in anaesthesia (Vega 1972 , Castro 1972 , Stovner, Endresen and 0sterud 1973 , Pearce 1974 prompted us to evaluate intravenous flunitrazepam as an induction agent.
MATERIALS AND METHODS

Drug Solution
The active principle of flunitrazepam is unstable in solution on long term storage. Thus the parenteral preparation of 1·0 mg per ml was obtained by mixing 2 mg of the drug dissolved in 1·0 ml alcoholic solvent (propylene glycol) with 1·0 ml water immediately before use.
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the dor~um of the right hand. Lumbar epidural analgesia was then performed usmg a standardized tec hni<lue and :!O ml 1· 5 °0 lignocaine \\"ith 1/:200,O()O adrenaline. \Yith the establishment of epidural blockade, f1unitrazepam in a dose of 2 mg, ;3 mg or J mg was rapidly injected through the infusion tubing at the rate of l'O ml per second. Table I shows the number of patients studied in the three different dosage groups together with the mean age, weight and height; as can be seen the mean age, weight and height of the three groups are broadly comparable.
Assessment
Immediately following injection, the patient was engaged in conversation until sleep supervened. Onset of sleep was determined by the loss of eyelid reflex and depth of sleep was graded as follows: Awake Grade 1 : Drowsy-eyelid reflex intact and able to reply to questions.
Grade 2 : Light sleep-eyelid reflex obtunded but able to respond to commands.
Grade 8 : Deep sleep-eyelid reflex obtunded and unable to respond to commands.
Blood pressure, pulse and respiratory rates were measured before induction and every five minutes thereafter until completion of surgery. The patient was closely observed during induction and throughout anaesthesia for occurrence of side effects. During recovery, a note was taken of the time when the patient opened her eyes on command and when she was able to answer questions. In the post-operative period, the patient was interviewed and the injection site examined for phlebitis. She was questioned on the occurrence of complications in the post-anaesthetic period and was asked to recall events prior to and following anaesthesia. Her view on f1unitrazepam as an induction agent was also ascertained.
I(ESCLTS
During induction, the speech became slurred and thickened about ;30-ijO seconds from the start of injection; yawning and lateral nystagmus were often noticed. \Yith the onset of sleep, there was reduction in the tone of the jaw muscles necessitating support of the mandible to maintain a clear airway. The laryngeal reflexes remained intact and insertion of an oropharyngeal airway was usually not tolerated. Two patients were found to have pinpoint pupils. The induction time was variable, exceeding one minute in the majority of patients and seemed to be related to dose (Table 2) . Sleep was produced within one minute in 37·5'% of patients receiving -i mg compared with 10'10 for those in the lower dosage groups. Five patients in the 2 mg group (25%) and three patients in the 3 mg group (1;'5%) failed to become unconscious whilst those who received J mg were all anaesthetized. 
The level of unconsciousness attained by the three groups is shown in Table 8 . Fluctuating levels of sleep were frequently encountered, the patient responding to command at one moment would relapse into sleep again a short while later. Those patients who remained awake after injection were calm and cooperative, two of them appeared drunk and were rather talkative. The duration of sleep varied A naestliesia and Intcnsil'c Care, ro/. IT', l'·:o. 4. l\'ovember, 1[176 markedly in the 4 mg group, the time from sleep onset to return of ability to obey simple commands ranged from 5 ·25-125 ·67 minutes with a mean of 47·7 minutes, and the time to return of ability to answer questions ranged from 51'75-384 minutes with a mean of 137 minutes (Table 4 ). The recovery stage was (55) 15 (75) 40 (100) prolonged, the patient often remained drowsy for several hours following return of ability to answer questions. Analysis of the changes in blood pressure, pulse and respiratory rates reveals that the drug produced a small fall in systolic blood pressure and pulse rate and a small increase in diastolic blood pressure and respiratory rate. The difference from control values was statistically significant for systolic pressure, pulse and respiratory rates in the 4 mg group (Table 5 ).
The incidence of induction complications and sequelae are tabulated in Table 6 . Pain along the vein during injection was prevalent among patients recelvmg 4 mg. Some patients experienced a feeling of numbness rather than pain during injection. The excitatory effects encountered were hiccup, cough and involuntary limb movements and were of a transient nature. Two patients in the 4 mg group were apnoeic for about one minute at induction. Dizziness was the most frequent complaint in the postanaesthetic period. Two patients objected to having the test drug again for induction if the need arises because of prolonged and distressing postoperative dizziness. Restlessness during emergence (four patients) was a feature in the initial part of the study. Subsequently, the Group ---2 mg 3mg 4mg 
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timely administration of intravenous pethidine for pain relief following regression of epidural blockade prevented its occurrence. Despite the high incidence of severe pain in the arm during injection, only 4 (10%) patients (all in the 4 mg group) developed phlebitis. There was remarkably little nausea (1 patient) or vomiting (3 patients). Amnesia from the time of injection was present in all anaesthetized patients; some of them also had retrograde amnesia. Even in patients who failed to become unconscious, there were lapses in their memories of events in the operative and post-operative periods. All patients considered the induction pleasant and the patient acceptance rate was high (97 ·5%). Sequelae Nausea 1 (5) 0 0 Vomiting 1 (5) 1 (5) 1 (2· 5) Dizziness 5 (25) 2 (10) 16 (40) l{estlessness 1 (5) 1 (5) 2 (5) Phlebitis 2 (10) 1 (5) 4 (10)
DISCUSSION
Diazepam has attracted much attention as an intravenous induction agent but failed to gain wide acceptance because of the marked individual variation in the sleep-inducing dose, delay in onset and recovery and pain during injection (Brown and Dundee 1968). The generally held view that diazepam exerts no depressant action on the cardiovascular system has to be revised. Rao et al. (1973) have shown that cardiac output was not affected at low dosage (0 ·13 mg/kg), but that there was a 30% decrease in stroke volume in healthy patients receiving large dosage (0· 77 mg/kg).
From the results of our limited clinical study, flunitrazepam appears to be a safe and satisfactory induction agent and an improvement on diazepam. A dose of 4 mg in adult women invariably produced sleep which came on within one minute in more than one third of patients. The drug however cannot be classed with the conventional rapid acting intravenous anaesthetic induction agents such as thiopentone, prop ani did and althesin, which will consistently produce loss of consciousness within one minute of injection. The sleep-inducing dose required in our trial was rather high when compared with other studies (Stovner et al. 1973 , Pearce 1974 ; the possible explanation is that our patients were healthy and unpremedicated and were fully conscious and alert just prior to induction. We employed an extremely rapid injection rate in order to facilitate estimation of the time of sleep onset, and this could account for the high incidence of local intolerance and the occurrence of apnoea at induction. The respiratory depressant action of the drug has been documented by Pearce (1974) , who found a significant increase in PaC0 2 shortly after induction. Our finding of a relatively stable cardiovascular system with only a small fall in systolic blood pressure and pulse rate was in agreement with that of Stovner et al. (1973) . The prolonged recovery period, together with the absence of analgesic property of the drug, warrants close observation of the patient in the post-operative period.
